Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Boswellic acids reduce TH17 differentiation via blockade of IL-1β-Mediated IRAK1 signaling.
The current role of mitoxantrone in the treatment of multiple sclerosis.
Molecular mechanisms of scar-sourced axon growth inhibitors.
Intensity of treadmill walking exercise on acute mood symptoms in persons with multiple sclerosis.
Botulinum Toxin Treatment of Spasticity in Adults and Children.
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression.
Axonal degeneration in multiple sclerosis: defining therapeutic targets by identifying the causes of pathology.
Alterations in Functional and Structural Connectivity in Pediatric-Onset Multiple Sclerosis.
RNA sequencing of microglia and monocyte-derived macrophages from mice with experimental autoimmune encephalomyelitis illustrates a changing phenotype with disease course.
A pilot randomized trial of progressive resistance exercise augmented by neuromuscular electrical stimulation for people with Multiple Sclerosis who use walking aids.
Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications.
Regression to the Mean and Predictors of MRI Disease Activity in RRMS Placebo Cohorts - Is There a Place for Baseline-to-Treatment Studies in MS?
Variant of multiple sclerosis with dementia and tumefactive demyelinating brain lesions.
Immunoenrichment microwave & magnetic (IM(2) ) proteomics for quantifying CD47 in the EAE model of multiple sclerosis.
Relationship between NF-κB1 -94 ins/del ATTG polymorphism and susceptibility of multiple sclerosis in Iranian MS patients.
Interferon Beta and Long-term Disability in Multiple Sclerosis-Reply.
Safety, anxiety and natalizumab continuation in JC virus-seropositive MS patients.
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Inhibitory saccadic dysfunction is associated with cerebellar injury in multiple sclerosis.
Efficacy and safety of natalizumab treatment for relapsing-remitting multiple sclerosis: interim results of the tysabri(r) observational programme in the uk.
Radiologically isolated syndrome: an uncommon finding at a university clinic in a high-prevalence region for multiple sclerosis.
Selectins and their ligands as potential immunotherapeutic targets in neurological diseases.
Anti-myelin antibodies play an important role in the susceptibility to develop PLP-induced EAE.
T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.

Pages